{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:21:30Z","timestamp":1791591690377,"version":"4.3.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.urolonc.2016.10.016","type":"journal-article","created":{"date-parts":[[2016,11,22]],"date-time":"2016-11-22T04:18:33Z","timestamp":1479788313000},"page":"113.e1-113.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Intravesical chemotherapy use after radical nephroureterectomy: A national survey of urologic oncologists"],"prefix":"10.1016","volume":"35","author":[{"given":"Diane D.","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Boorjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay D.","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2016.10.016_bib1","series-title":"Urology","article-title":"Campbell-Walsh","author":"Smith","year":"2015"},{"key":"10.1016\/j.urolonc.2016.10.016_bib2","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/ncpuro0875","article-title":"Management of patients with upper urinary tract transitional cell carcinoma","volume":"4","author":"Raman","year":"2007","journal-title":"Nat Clin Pract Urol"},{"key":"10.1016\/j.urolonc.2016.10.016_bib3","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/iju.12121","article-title":"Bladder recurrence after radical nephroureterectomy: predictors and impact on oncological outcomes","volume":"20","author":"Elalouf","year":"2013","journal-title":"Int J Urol"},{"key":"10.1016\/j.urolonc.2016.10.016_bib4","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.urolonc.2014.04.006","article-title":"Risk factors for bladder cancer recurrence after nephroureterectomy for upper tract urothelial tumors: results from the Canadian Upper Tract Collaboration","volume":"32","author":"Fradet","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2016.10.016_bib5","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/bju.12707","article-title":"Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomy","volume":"115","author":"Ishioka","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2016.10.016_bib6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00345-012-0957-3","article-title":"Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: predictors and impact on subsequent oncological outcomes from a national multicenter study","volume":"31","author":"Xylinas","year":"2012","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2016.10.016_bib7","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.eururo.2012.04.052","article-title":"Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma","volume":"65","author":"Xylinas","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2016.10.016_bib8","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.eururo.2009.12.032","article-title":"Oncologic outcomes following three different approaches to the distal ureter and bladder cuff in nephroureterectomy for primary upper urinary tract urothelial carcinoma","volume":"57","author":"Li","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2016.10.016_bib9","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.eururo.2011.05.064","article-title":"Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial)","volume":"60","author":"O\u2019Brien","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2016.10.016_bib10","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1200\/JCO.2012.45.2128","article-title":"Prospective Randomized Phase II Trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial","volume":"31","author":"Ito","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2016.10.016_bib11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.juro.2009.08.154","article-title":"Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy?","volume":"183","author":"Wu","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2016.10.016_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12894-015-0039-0","article-title":"Evaluating the safety of intraoperative instillation of intravesical chemotherapy at the time of nephroureterectomy","volume":"15","author":"Moriarty","year":"2015","journal-title":"BMC Urol"},{"key":"10.1016\/j.urolonc.2016.10.016_bib13","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.eururo.2015.06.044","article-title":"European association of urology guidelines on upper urinary tract urothelial cell carcinoma: 2015 update","volume":"68","author":"Roupr\u00eat","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2016.10.016_bib14","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1158\/1078-0432.CCR-05-0891","article-title":"Molecular evidence supporting field effect in urothelial carcinogenesis","volume":"11","author":"Jones","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2016.10.016_bib15","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/jjco\/hyt129","article-title":"Intravesical seeding of upper urinary tract urothelial carcinoma cells during nephroureterectomy: an exploratory analysis from the THPMG Trial","volume":"43","author":"Ito","year":"2013","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.urolonc.2016.10.016_bib16","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.eururo.2014.11.035","article-title":"A systematic review and meta-analysis of clinicopathologic factors linked to intravesical recurrence after radical nephroureterectomy to treat upper tract urothelial carcinoma","volume":"67","author":"Seisen","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2016.10.016_bib17","first-page":"4734","article-title":"Prognostic value and efficacy valuation of postoperative intravesical instillation in primary urothelial carcinomas of upper urinary tract","volume":"7","author":"Deng","year":"2014","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.urolonc.2016.10.016_bib18","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1046\/j.1442-2042.2001.00286.x","article-title":"Prophylactic intravesical instillation of mitomycin C and cytosine arabinoside for prevention of recurrent bladder tumors following surgery for upper urinary tract tumors: a prospective randomized study","volume":"8","author":"Sakamoto","year":"2001","journal-title":"Int J Urol"},{"key":"10.1016\/j.urolonc.2016.10.016_bib19","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1464-410X.2006.05970.x","article-title":"Chemo-prevention in superficial bladder cancer using mitomycin C: a survey of the practice patterns of British urologists","volume":"97","author":"Clarke","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2016.10.016_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/iju.12630","volume":"22","author":"Oya","year":"2014","journal-title":"Int J Urol"},{"key":"10.1016\/j.urolonc.2016.10.016_bib21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0094-0143(05)70240-8","article-title":"An overview of the treatment of superficial bladder cancer. Intravesical chemotherapy","volume":"27","author":"Duque","year":"2000","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urolonc.2016.10.016_bib22","first-page":"1229","article-title":"Prophylactic intravesical chemotherapy decreases bladder tumor recurrence after nephroureterectomy for primary upper tract urothelial carcinoma: a systematic review and meta-analysis","volume":"20","author":"Wu","year":"2015","journal-title":"J BUON"},{"key":"10.1016\/j.urolonc.2016.10.016_bib23","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.juro.2011.12.056","article-title":"National practice patterns for immediate postoperative instillation of chemotherapy in nonmuscle invasive bladder cancer","volume":"187","author":"Cookson","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2016.10.016_bib24","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.juro.2013.06.025","article-title":"Practice based collaboration to improve the use of immediate intravesical therapy after resection of nonmuscle invasive bladder cancer","volume":"190","author":"Barocas","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2016.10.016_bib25","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/jjco\/hyw072","article-title":"Clinical practice patterns for upper tract urothelial carcinoma: a nationwide survey in Japan","volume":"46","author":"Kikuchi","year":"2016","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.urolonc.2016.10.016_bib26","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.eururo.2013.09.003","article-title":"Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool","volume":"65","author":"Xylinas","year":"2014","journal-title":"Eur Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107814391630326X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107814391630326X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:09:09Z","timestamp":1761041349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107814391630326X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S107814391630326X"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2016.10.016","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravesical chemotherapy use after radical nephroureterectomy: A national survey of urologic oncologists","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2016.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}